TM
AGIO icon

Torren Management’s Agios Pharmaceuticals AGIO Stock Holding History

Torren Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-615
Closed -$16.7K – 993
2025
Q4 		$16.7K Buy
+615
New +$21.6K 0.01% 635

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Torren Management's AGIO Position: Q1 2026 in Review

Torren Management sold out of Agios Pharmaceuticals (AGIO) in Q1 2026, closing a stake of 615 shares — an estimated $16.7K sold.

Torren Management first reported a position in AGIO in Q4 2025 and held it in 1 quarter. The position peaked at $16.7K in Q4 2025. 233 funds tracked by Wall St. Rank hold AGIO as of Q1 2026.

  • Torren Management reported no remaining Agios Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Torren Management sold 615 Agios Pharmaceuticals shares in Q1 2026, an estimated $16.7K.
  • Torren Management first reported a position in Agios Pharmaceuticals in Q4 2025 and held it in 1 quarter.
  • Torren Management's Agios Pharmaceuticals position peaked at $16.7K in Q4 2025.
  • 233 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q1 2026.

Based on Torren Management's 13F filing for Q1 2026, filed 30 Apr 2026.